Current Report Filing (8-k)
July 29 2016 - 4:03PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 25, 2016
TRACON Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-36818
|
|
34-2037594
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
8910 University Center Lane, Suite 700
San Diego, California
|
|
92122
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (858) 550-0780
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On July 25, 2016, Dr. Ronald Shazer notified us that he was resigning as the Companys Chief Medical Officer. We expect that
Dr. Shazers last day of employment will be August 5, 2016, after which we expect to retain Dr. Shazer as a consultant. Dr. Charles Theuer, the Companys President and Chief Executive Officer, will resume oversight of
clinical development.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
TRACON Pharmaceuticals, Inc.
|
|
|
|
|
Dated: July 29, 2016
|
|
|
|
By:
|
|
/s/ Charles P. Theuer, M.D., Ph.D.
|
|
|
|
|
|
|
Charles P. Theuer, M.D., Ph.D.
|
|
|
|
|
|
|
President and Chief Executive Officer
|
TRACON Pharmaceuticals (NASDAQ:TCON)
Historical Stock Chart
From Mar 2024 to Apr 2024
TRACON Pharmaceuticals (NASDAQ:TCON)
Historical Stock Chart
From Apr 2023 to Apr 2024